Vaccine manufacturing takes place in one of the most demanding environments in the pharmaceutical industry. The need to guarantee sterility, product efficacy, and patient safety requires strict control at every stage of the process. In this context, equipment qualification stands as a fundamental pillar, especially following the update to EU GMP Annex 1, which reinforces applicable requirements for the manufacture of sterile medicinal products.
In this article, we explain the importance of equipment qualification aligned with Annex 1 requirements, promoting regulatory compliance and confidence in the final product.
Equipment qualification and Annex 1 expectations
Equipment qualification is the documented process demonstrating that equipment is suitable for its intended use, correctly installed, and operates consistently with reproducible results within defined parameters. In vaccine production, where sensitive biological products are handled, minor deviations can significantly impact final product quality.
Annex 1 focuses particularly on contamination prevention, environmental control, and equipment/system design, requiring clear evidence that these aspects have been considered from the initial stages of the equipment lifecycle.
Equipos críticos en la fabricación de vacunas
In line with the Annex 1 approach, equipment that has a direct impact on sterility and product quality must be prioritized for identification and qualification. Key equipment in vaccine production includes:
These systems must be designed to facilitate cleaning, disinfection, and sterilization, as well as to minimize human intervention.
Phases of qualification under a lifecycle approach
The equipment qualification process in production is typically structured into the following phases:
Design Qualification (DQ)
Verifies that the equipment design complies with Annex 1 principles, including suitable materials, contamination control, and compatibility with aseptic processes.
Installation Qualification (IQ)
Documents that the equipment has been correctly installed, paying special attention to critical utilities, instrumentation, and environmental conditions.
Operational Qualification (OQ)
Verifies that the equipment operates correctly within defined ranges, including testing alarms, interlocks, and critical parameters. The main goal is to demonstrate robust, reliable, and reproducible operation to ensure stable production aligned with expected market quality standards.
Performance Qualification (PQ)
Confirms that the equipment maintains consistent performance under actual production conditions, as required by Annex 1 to demonstrate process control.
Risk Management and Continuous Improvement
Annex 1 reinforces the use of a risk-based approach, which entails adapting the depth of qualification to the criticality of the equipment and process. This approach optimizes resources, improves contamination control, and facilitates change management throughout the equipment lifecycle.
Ensuring regulatory compliance
Equipment qualification in vaccine production, aligned with Annex 1 requirements, is a key tool for ensuring robust, reliable, and reproducible processes, high-quality products, and strong regulatory compliance. Beyond normative obligation, it is a strategic investment in quality, efficiency, and confidence in the final product.
At Ambit Iberia, we offer consulting and auditing services in equipment and facility qualification to help you excel in the regulated sector and ensure product quality. If you want to learn more, click here and get in touch with us.
For over 20 years, Ambit Iberia has been an expert in developing IT strategies and solutions. We help the pharmaceutical, medical device, and IVD (in vitro diagnostics) sectors comply with regulations throughout the entire product lifecycle. We design and implement innovative infrastructures leveraging a global service offering as a key driver for digital transformation.